Abstract:
Substituted cinnamoyl anthranilate compounds exhibiting anti-fibrotic activity; or derivatives thereof, analogues thereof, pharmaceutically acceptable salts thereof, and metabolites thereof; with the proviso that the compound is not Tranilast.
Abstract:
Polymeric networks can be obtained by condensing an aldehyde or a mixture of aldehydes or precursors thereof with a component A containing amines, optionally in the presence of a solvent S. Component A contains at least one polyetheramine (I) which can be obtained by alkoxylation of polyols of general formula Y (-OH)s, wherein Y means an s-valent organic radical and s means an integral value from 4 to 20, with 1 to 100 mol per mol hydroxyl groups or one or more C1-8-alkylene oxides, and subsequent amination with ammonia, so that 50 to 100 % of the hydroxyl groups are aminated and there are at least two primary amino groups per molecule; optionally, at least one amine of formula (II) Y (-NH2)n and optionally, at least one amine of formula (III) (Z-)(q-r)Y (-NH2)r, wherein Y means n-valent organic radicals, Y means q-valent organic radicals, Z means functional monovalent radicals, n means an integral value from 1 to 20, q means an integral value from 2 to 20 and r means an integral value from 1 to 19 on the condition that 1
Abstract:
The invention relates to a novel method for the production of 2-heterocyclyl methyl benzoic acid derivatives of general formula (I), wherein n, X and Z have the meaning cited in the description, providing good yields and high purity. The invention is characterized in that phthalide of general formula (II), wherein n and X have the meaning cited in the description, is reacted with nitrogen heterocycles of general formula (III): H-Z, wherein Z has the meaning cited in the description, or with nitrogen heterocycle metal salts of general formula (II) in the presence of an aprotic polar diluent and optionally in the presence of a basic auxiliary reaction agent.
Abstract:
Use of subtsituted 4-Biarylbutyric and 5-Biarylpentanoic Acid Derivatives for the Treatment of Cerebral Diseases, pharmaceutical compositions containing them, and a process for using them. The compounds of the invention have the generalized formula (I): (T)xA-B-D-E-CO2H, wherein A is an aryl or heteroaryl rings; B is an aryl or heteroaryl ring or a bond; each T is a substituent group; x is 0,1, or 2; the group D represents (a), or (b), the group E represents a two or three carbon chain bearing one to three substituent groups which are independent or are involved in ring formation, possible structures being shown in the text and claims; and each of the substituents on E is an independent substituent; and includes pharmaceutically acceptable salts thereof.
Abstract:
The present invention is directed to compounds represented by the following structural formula, Formula I: wherein: (a) X is selected from the group consisting of a single bond, O, S, S(O)2 and N; (b) U is an aliphatic linker; (c) Y is selected from the group consisting of O, C, S, NH and a single bond; (d) E is C(R3)(R4)A or A and wherein (i) A is selected from the group consisting of carboxyl, tetrazole, C1-C6 alkylnitrile, carboxamide, sulfonamide and acylsulfonamide; (e) Z1 and Z2 are each independently selected from the group consisting of N, O, and C with the proviso that at least one of Z1 and Z2 is N; (f) Z3 is selected from the group consisting of N, O, and C. (g) R8 is selected from the group consisting of hydrogen, C1-C6 alkyl, C1-C4 alkylenyl and halo; (h) R9 is selected from the group consisting of hydrogen, C1-C4 alkyl, C1-C4 alkylenyl, halo, aryl- C0-C4 alkyl, heteroaryl, C1-C6 allyl, and OR29.
Abstract:
The present invention relates to the use of a compound of formula I as a coupling reagent in forming amide or ester bonds from a reaction between a carboxylic acid and an amine or an alcohol, respectively. The compounds of formula I are especially useful as coupling reagents in the preparation of peptide bonds during peptide synthesis. In particular, the compounds of formula I are useful in promoting the formation of reactive reaction intermediates, inhibiting side reactions and in suppression of racemization. In addition, the present invention provides novel compounds of Formula I, and salts of N-oxides thereof.
Abstract:
Use of compounds to inhibit hormone-sensitive lipase, pharmaceutical compositions comprising the compounds, methods of treatment employing these compounds and compositions, and novel compounds. The present compounds are inhibitors of hormone-sensitive lipase and may be useful in the treatment and/or prevention of medical disorders where a decreased activity of hormone-sensitive lipase is desirable.
Abstract:
The invention relates to the inhibition of histone deacetylase. The invention provides compounds and methods for inhibiting histone deacetylase enzymatic activity. The invention also provides compositions and methods for treating cell proliferative diseases and conditions.
Abstract:
Use of subtsituted 4-Biarylbutyric and 5-Biarylpentanoic Acid Derivatives for the Treatment of Cerebral Diseases, pharmaceutical compositions containing them, and a process for using them. The compounds of the invention have the generalized formula (I): (T)xA-B-D-E-CO2H, wherein A is an aryl or heteroaryl rings; B is an aryl or heteroaryl ring or a bond; each T is a substituent group; x is 0,1, or 2; the group D represents (a), or (b), the group E represents a two or three carbon chain bearing one to three substituent groups which are independent or are involved in ring formation, possible structures being shown in the text and claims; and each of the substituents on E is an independent substituent; and includes pharmaceutically acceptable salts thereof.
Abstract:
The present disclosure is directed to non-corrosive cleaning compositions that are useful, e.g., for removing residues (e.g., plasma etch and/or plasma ashing residues) and/or metal oxides from a semiconductor substrate as an intermediate step in a multistep manufacturing process.